This article highlights the epidemiology and pathophysiology of pheochromocytomas and paragangliomas. The current management of pheochromocytoma and paragangliomas, including utilization and interpretation of biochemical testing, preoperative imaging, and genetic screening are discussed. Furthermore, perioperative surgical management, outcomes, and recommended follow-up are reviewed.
Keywords: Biochemical evaluation; Genetics; Imaging; Neuroendocrine tumor; Paraganglioma; Perioperative management; Pheochromocytoma; Surgery.
Copyright © 2016 Elsevier Inc. All rights reserved.